@TheBioMAHunter I think today’s earnings call will speak volumes. Market will be waiting to hear updates on the NDA (i.e if filed), and their ability to protect and a solid response generally to USONA
@Caleb_Crann Agreed.
With the broader weakness in equities - a catalyst is needed. All close to or around major higher time frame support. NDA filing for CMPS would be sweet right about now..
@JTheretohelp1 For sure I agree with your thoughts regarding what was crypto. However that aside - if four year cycles are still in play, would MSTR not be a good beta asset to BTC?
@RobinLauber_@RandyMarsh1100@Caleb_Crann I feel these existing Spravato clinics would have reasonable idea already. Something J&J could also easily find out.
@RobinLauber_@RandyMarsh1100@Caleb_Crann Robin, what’s your take on how is big pharma viewing Compass? Are they waiting patiently for REMs, approval etc or disinterested?
@DrDreidel2@kevin__mak I hope you get an answer, but do note nothing has fundamentally changed with CMPS (and likely thus Kevin's thesis) - apart from the price.
@moonshilla@bertcoincto Pengu is just a quick one for example. I get the idea. Multi year trendline being broken or about to break with an expectation of a parabolic 400-500x. Just seems highly unlikely on the basis of just a fractal.